戻る Agenda
Special Population Study Challenges
Session Chair(s)
William B. Smith, MD
CEO
Alliance for Multispecialty Research, LLC , United States
Early phase pharmacokinetic studies continue to be challenging. Current issues from regulatory, CRO/Sponsor, and site perspectives will be discussed and suggestions for optimizing protocols and operations will be presented.
Learning Objective : Describe the design challenges of special population studies; Develop practical solutions to special population study obstacles.
Speaker(s)
Critical Challenges in Conducting PK Studies in Patients and Special Populations
Charu Gautam, MD
IQVIA, India
Senior Director- Medical Science and Strategy
Special Population Studies: Thirty Years Experience Shared
Harry Alcorn, PHARMD
Elixia Health, United States
Chief Scientific Officer